Since we found increased CSF-decorin levels in the early preclinical stage of AD, we were interested in the CSF-decorin changes in the AppNL-F/NL-F mice exhibiting a mild Aβ pathology and how it is changed upon development of the Aβ amyloidosis. Here, DCN is linked to Alzheimer disease.